What the new FTC guidelines mean for the future of supplement claims
Radicle Science
Proving the true effects of health and wellness products beyond placebo.
There has been long standing uncertainty regarding permissible structure/function claims for supplements. The 1998 Federal Trade Commission (FTC) publication “Dietary Supplements: An Advertising Guide for Industry” has been one of the few government publications on this topic, but it left much unstated. FTC’s hot-off-the press Dec 2022 “Health Products Compliance Guidance” is a game-changer. For the first time in nearly a quarter century, the FTC revised their guidance and loaded it with 50+ explicit examples of permissible vs. impermissible claims.
The “competent and reliable scientific evidence standard” was expanded to emphasize the general rule that FTC expects companies to support any health-related claims with high-quality, randomized, controlled human clinical trials (RCTs). Some say this signals a forthcoming wave of FTC crackdowns, others say that fear is overblown. But there is broad agreement that with this new revised guidance, the quality of data needed for claims (and the risks from making claims) will be higher going forward–helping put the proof back in claims.
Radicle Partnerships
?"UNPA and Radicle Science launch clinical trial partnership" Nutra Ingredients USA
This exciting collaboration aims to level the playing field between supplements and pharmaceuticals by giving UNPA members access to groundbreaking clinical trials on supplements.
From Our Blog
领英推荐
Resources